APR 30, 2015 7:34 AM PDT

New Mechanism Found to Control Cell Response to DNA Damage

WRITTEN BY: Judy O'Rourke
DNA can be damaged by different environmental insults, such as ultraviolet light, ionizing radiation, oxidative stress or certain drugs.

If the DNA is not repaired, cells may begin growing uncontrollably, leading to the development of cancer. Therefore, cells must maintain an intricate regulatory network to ensure that their DNA remains intact. Moffitt Cancer Center researchers have discovered a novel mechanism that controls a cell's response to DNA damage.

The protein SIRT1 plays an important role in controlling DNA damage. It can sense the presence of DNA damage, signal to other proteins that damage exists, aid in the repair of damage and stimulate cell death if the damage cannot be repaired.

Moffitt researchers found that SIRT1 is modified by a process called ubiquitination, in which a small residue called ubiquitin is added to SIRT1. This modification allows SIRT1 to relay information about DNA damage to other proteins, leading to either DNA repair or cell death.

The researchers performed studies to determine how ubiquitin modification changes SIRT1 function. They discovered that cells respond to ubiquitin modification of SIRT1 differently according to the type of environmental insult that occurs. If cells are exposed to a drug called etoposide, SIRT1 ubiquitination blocks cell death. However, if cells are exposed to oxidative stress, SIRT1 ubiquitination promotes cell death.

These results are important because they increase scientists' understanding of how proteins and cells function, potentially leading to more effective therapeutic drugs in the future.

"SIRT1 is known to be abnormally expressed in a variety of cancers and might be a good target for therapy," says Ed Seto, PhD, senior member, Cancer Biology and Evolution Program, Moffitt. "Ubiquitin-proteasome inhibitors have already been successfully used in cancer therapy and clinical trials. Therefore, this research might provide molecular bases and insights for developing additional therapeutic strategies in the future."

The research, in an article titled "Ubiquitinated Sirtuin 1 (SIRT1) Function Is Modulated during DNA Damage-induced Cell Death and Survival," was published in The Journal of Biological Chemistry.

[Source: Moffitt Cancer Center]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
NOV 19, 2019
Cancer
NOV 19, 2019
When the numbers don't match: inaccuracy in late state breast cancer survival estimates
According to the World Health Organization, about 2.1 million women are diagnosed with breast cancer annually. It is the cancer that most affects women and...
NOV 29, 2019
Cancer
NOV 29, 2019
How flavonoids fight against colorectal cancer
New research published in the journal Cancers reports why flavonoids can aid in reducing the risk of colorectal cancer. Flavonoids are compounds found in f...
JAN 08, 2020
Health & Medicine
JAN 08, 2020
Cancer Death Rates Declining in U.S., According to New Report
In the United States, the death rate from cancer has declined, according to a new report released today by the American Cancer Society. The video below sum...
JAN 13, 2020
Cancer
JAN 13, 2020
The anti-cancer properties of bitter melon
New research published in the journal Cell Communication and Signaling suggests that bitter melon, also known as bitter gourd, may have anti-cancer propert...
JAN 20, 2020
Genetics & Genomics
JAN 20, 2020
Epigenetic Changes Make Breast Cancer Cells Drug Resistant
Researchers have found that changes in the structure of the genome in breast cancer cells can make them resistant to drug therapies....
FEB 05, 2020
Genetics & Genomics
FEB 05, 2020
'Chromosome Shattering' is Common Across Cancer Types
A type of genetic mutation called chromothripsis was discovered a few years ago in chronic lymphocytic leukemia....
Loading Comments...